Honeywell HomMed's Genesis Touch Named As Finalist In The 2013 Medical Design Excellence Awards

AUSTIN, Texas – Honeywell (NYSE: HON) HomMed, a global leader in telehealth and remote patient care, today announced its Genesis Touch has been selected as a finalist in the 15^th Annual Medical Design Excellence Awards (MDEA) competition.

Evaluated by the panel of third-party MDEA jurors, the Genesis Touch is Honeywell’s wireless remote patient monitoring device, allowing patients to take their biometric information and communicate it with healthcare providers.  Its intuitive user interface also offers features such as an integrated video application, ability to schedule biometrics collection and Spanish language support.

“We are honored the Genesis Touch has been recognized as a finalist in this year’s Medical Design Excellence Awards,” said John Bojanowski, President of Honeywell HomMed. “The Genesis Touch combines traditional telehealth benefits with the newest technological services, offering healthcare providers, patients and their families the best – and most flexible – remote patient monitoring possible.”

The Medical Design Excellence Awards (www.MDEAwards.com) is the industry’s premier design awards competition and the only awards program to exclusively recognize contributions and advances in the design of medical products. 

MDEA entries were evaluated by an impartial, multidisciplinary panel of third-party jurors, and judged on the basis of their design and engineering features, including innovative use of materials, user-related functions improving healthcare delivery and changing traditional medical attitudes or practices, features providing enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so the product meets its clinical objectives.

About Honeywell:

Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes, and industry; turbochargers; and performance materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com. 

About Honeywell HomMed:

Headquartered in Brookfield, Wis., Honeywell HomMed, part of Honeywell Automation and Control Solutions, is a global leader in telehealth and remote patient care, providing the healthcare industry with integrated product and service solutions designed to improve the quality of patients' lives and reduce the cost of healthcare.  For more information about Honeywell HomMed, please visit www.hommed.com.

This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.